Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), has long been a significant cause of severe disease and death. At the same time, its etiology is regarded as multifactorial and not well-defined. The annual incidence rate of VTE in people of European ancestry is estimated to range from 104 to 183 per 100,000 person-years, and it is believed to vary between people of different ethnicities [1]. It is well documented that there is a high morbidity and mortality associated with VTE, and it is highlighted as a medical emergency requiring urgent intervention [2].
